(Q34075093)

30 July 2017

1 reference

title

Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders (English)

1 reference

30 July 2017

2

Popik P

1 reference

30 July 2017

1

Bisaga A

1 reference

30 July 2017

4

Danysz W

1 reference

30 July 2017

Bespalov AY

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

Expert Opinion on Investigational Drugs

30 July 2017

published in

1 reference

30 July 2017

volume

9

1 reference

30 July 2017

issue

10

1 reference

30 July 2017

page(s)

2233-2248

1 reference

Actual causes of death in the United States

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Chronic ethanol exposure and withdrawal influence NMDA receptor subunit and splice variant mRNA expression in the rat cerebral cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Region-specific changes in [3H]dizocilpine binding in diazepam-withdrawn rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Autoradiography of [3H]glutamate binding during pentobarbital tolerance and withdrawal in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Decrease of tolerance to, and physical dependence on morphine by, glutamate receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

The NMDA receptor competitive antagonist CPP modulates benzodiazepine tolerance and discontinuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

NMDA-R1 antisense oligonucleotide attenuates withdrawal signs from morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Effect of precipitated withdrawal on extracellular glutamate and aspartate in the nucleus accumbens of chronically morphine-treated rats: an in vivo microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Glutamate-induced increase of extracellular glutamate through N-methyl-D-aspartate receptors in ethanol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Ifenprodil influences changes in mouse behaviour related to acute and chronic ethanol administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Role of NMDA receptors in pentobarbital tolerance/dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

NMDA receptor antagonists potently suppress the spontaneous withdrawal signs induced by discontinuation of long-term diazepam treatment in Fischer 344 rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Sensitisation to repeated withdrawal, in mice treated chronically with diazepam, is blocked by an NMDA receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Effects of the NMDA receptor channel blockers memantine and MRZ 2/579 on morphine withdrawal-facilitated aggression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Effects of NMDA antagonists on ethanol-withdrawal induced "anxiety" in the elevated plus maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Synergistic effects of cocaine and dizocilpine (MK-801) on brain stimulation reward.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Site-specific NMDA receptor antagonists produce differential effects on cocaine self-administration in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Systemic pretreatment with MK-801 (dizocilpine) increases breaking points for self-administration of cocaine on a progressive-ratio schedule in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Effects of N-methyl-D-aspartate receptor antagonists on reinforced and nonreinforced responding for ethanol in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Response-reinforcement learning is dependent on N-methyl-D-aspartate receptor activation in the nucleus accumbens core

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Oral ethanol self-administration in rats is reduced by the administration of dopamine and glutamate receptor antagonists into the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Interactions between N-methyl-D-aspartate receptor antagonists and the discriminative stimulus effects of morphine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Modulation of the discriminative stimulus and rate-altering effects of cocaine by competitive and noncompetitive N-methyl-D-aspartate antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Discriminative stimulus effects of ethanol: neuropharmacological characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Inhibition by MK-801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Intraaccumbens administration of NMDA receptor antagonist (+/-)-CPP prevents locomotor activation conditioned by morphine and amphetamine in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

MK-801 inhibits methamphetamine-induced conditioned place preference and behavioral sensitization to apomorphine in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

NMDA receptor antagonists prevent conditioned activation of intracranial self-stimulation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Effects of NMDA receptor antagonists on cocaine-conditioned motor activity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

NMDA receptors mediate the behavioral effects of amphetamine infused into the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Effects of N-methyl-D-aspartate receptor antagonists on reinstatement of cocaine-seeking behavior by priming injections of cocaine or exposures to cocaine-associated cues in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Ethanol and amino acids in the central nervous system: assessment of the pharmacological actions of acamprosate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Antidepressants for the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Memantine does not substantially affect brain stimulation reward: comparison with MK-801.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Effects of the non-competitive NMDA-receptor antagonist memantine on morphine- and cocaine-induced potentiation of lateral hypothalamic brain stimulation reward.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Evaluation of the reinforcing properties and phencyclidine-like discriminative stimulus effects of dextromethorphan and dextrorphan in rats and rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

The neuroprotective glycine receptor antagonist GV150526 does not produce neuronal vacuolization or cognitive deficits in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Spatial learning without NMDA receptor-dependent long-term potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

The NMDA antagonist memantine impairs classical eyeblink conditioning in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.10.2233

10.1517/13543784.9.10.2233

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference